Michael Landsittel, CFO: Blueprint Medicines BPMC Sell · Filed 24/08/19

Trade details

Type: Insider sale
Amount: $419,869.07
Shares · price: 4,409 sh · $95.23 a share
Held after: 67,208 sh
Stock: Blueprint Medicines BPMC
Person: Michael LandsittelCFO
Trade date: 24/08/15
Filed: 24/08/19
Days to filing: 4 days

Sold 6.2% of holdings

Share of holding sold: 6.2%

Blueprint Medicines trades, last 26 weeks

What else happened in Blueprint Medicines around then

Filed or reported within 30 days of the trade day · 24/07/16~24/09/14

Michael Landsittel's recent trades

Michael LandsittelCFO
SellBlueprint Medicines
Sell
Blueprint Medicines
BPMC
$469.2K
5,284 sh
$469.2K
Filed 25/03/07
Traded 25/03/05
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$266.4K
2,486 sh
$266.4K
Filed 24/05/17
Traded 24/05/15
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$145.3K
1,364 sh
$145.3K
Filed 24/05/17
Traded 24/05/15
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$1.1M
10,000 sh
$1.1M
Filed 24/05/06
Traded 24/05/02
Michael LandsittelCFO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$475K
5,000 sh
$475K
Filed 24/04/01
Traded 24/03/28

Michael Landsittel, CFO — sold $419.9K of Blueprint Medicines BPMC · 6.2% of holdings · 10b5-1 plan | Whalegun